Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-052192)

Filing Details

Accession Number:: 0001181431-12-052192
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-09-27 16:08:26
Reporting Period:: 2012-09-25

Filing Date:: 2012-09-27
Accepted Time:: 2012-09-27 16:08:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1459450	Myrexis Inc.	MYRX	Pharmaceutical Preparations (2834)	263996918

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529269	Andrea Kendell	C/O Myrexis, Inc. 305 Chipeta Way Salt Lake City UT 84108	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-09-25	693	$2.34	33,094	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to an instruction given in accordance with Rule 10b5-1 by the Reporting Person on June 19, 2011, and was made to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock units granted on September 24, 2010.